MAPK phosphatase 7 regulates T cell differentiation via inhibiting ERK-mediated IL-2 expression

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3088-3095

  Zhang, Yongliang ^a   Nallaparaju, Kalyan C ^b   Liu, Xin ^c   Jiao, Huipeng ^a   Reynolds, Joseph M ^a   Wang, Zhi Xin ^b   Dong, Chen ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 7; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; DUAL SPECIFICITY PHOSPHATASE; DUSP16 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; EMBRYO; ENZYME ACTIVATION; ENZYME INACTIVATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FETUS; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LETHALITY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T FOLLICULAR HELPER CELL; T LYMPHOCYTE; TH17 CELL; ANIMAL; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOLOGY; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LETHAL GENE; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; DUAL-SPECIFICITY PHOSPHATASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GENES, LETHAL; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TH17 CELLS;

EID: 84925845009     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402638     Document Type: Article

References (45)

1. Zhang, Y., J. N. Blattman, N. J. Kennedy, J. Duong, T. Nguyen, Y. Wang, R. J. Davis, P. D. Greenberg, R. A. Flavell, and C. Dong. 2004. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430: 793-797.
2. Zhao, Q., X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203: 131-140.
3. Chi, H., S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones, A. M. Bennett, and R. A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA 103: 2274-2279.
4. Zhang, Y., J. M. Reynolds, S. H. Chang, N. Martin-Orozco, Y. Chung, R. I. Nurieva, and C. Dong. 2009. MKP-1 is necessary for T cell activation and function. J. Biol. Chem. 284: 30815-30824.
5. Liu, Y., E. G. Shepherd, and L. D. Nelin. 2007. MAPK phosphatases - regulating the immune response. Nat. Rev. Immunol. 7: 202-212.
6. Patterson, K. I., T. Brummer, P. M. O'Brien, and R. J. Daly. 2009. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 418: 475-489.
7. Tanoue, T., T. Yamamoto, R. Maeda, and E. Nishida. 2001. A novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J. Biol. Chem. 276: 26629-26639.
8. Masuda, K., H. Shima, M. Watanabe, and K. Kikuchi. 2001. MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein. J. Biol. Chem. 276: 39002-39011.
9. Willoughby, E. A., G. R. Perkins, M. K. Collins, and A. J. Whitmarsh. 2003. The JNK-interacting protein-1 scaffold protein targets MAPK phosphatase-7 to dephosphorylate JNK. J. Biol. Chem. 278: 10731-10736.
10. Willoughby, E. A., and M. K. Collins. 2005. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2. J. Biol. Chem. 280: 25651-25658.
11. Matsuguchi, T., T. Musikacharoen, T. R. Johnson, A. S. Kraft, and Y. Yoshikai. 2001. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol. Cell. Biol. 21: 6999-7009.
12. Niedzielska, M., B. Bodendorfer, S. Münch, A. Eichner, M. Derigs, O. da Costa, A. Schweizer, F. Neff, L. Nitschke, T. Sparwasser, et al. 2014. Gene trap mice reveal an essential function of dual specificity phosphatase Dusp16/MKP-7 in perinatal survival and regulation of Toll-like receptor (TLR)-induced cytokine production. J. Biol. Chem. 289: 2112-2126.
13. Dong, C., D. D. Yang, M. Wysk, A. J. Whitmarsh, R. J. Davis, and R. A. Flavell. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282: 2092-2095.
14. Angkasekwinai, P., H. Park, Y. H. Wang, Y. H. Wang, S. H. Chang, D. B. Corry, Y. J. Liu, Z. Zhu, and C. Dong. 2007. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204: 1509-1517.
15. Dong, C., A. E. Juedes, U. A. Temann, S. Shresta, J. P. Allison, N. H. Ruddle, and R. A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409: 97-101.
16. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348.
17. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
18. Groom, L. A., A. A. Sneddon, D. R. Alessi, S. Dowd, and S. M. Keyse. 1996. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 15: 3621-3632.
19. Li, C., D. A. Scott, E. Hatch, X. Tian, and S. L. Mansour. 2007. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 134: 167-176.
20. Anderson, N. G., J. L. Maller, N. K. Tonks, and T. W. Sturgill. 1990. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343: 651-653.
21. Whitehurst, C. E., and T. D. Geppert. 1996. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 156: 1020-1029.
22. Smith-Garvin, J. E., G. A. Koretzky, and M. S. Jordan. 2009. T cell activation. Annu. Rev. Immunol. 27: 591-619.
23. Gronda, M., S. Arab, B. Iafrate, H. Suzuki, and B. W. Zanke. 2001. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. Mol. Cell. Biol. 21: 6851-6858.
24. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
25. Liu, X., R. I. Nurieva, and C. Dong. 2013. Transcriptional regulation of follicular T-helper (Tfh) cells. Immunol. Rev. 252: 139-145.
26. Liu, X., X. Yan, B. Zhong, R. I. Nurieva, A. Wang, X. Wang, N. Martin-Orozco, Y. Wang, S. H. Chang, E. Esplugues, et al. 2012. Bcl6 expression specifies the T follicular helper cell program in vivo. J. Exp. Med. 209: 1841-1852, S1-S24.
27. Hatano, N., Y. Mori, M. Oh-hora, A. Kosugi, T. Fujikawa, N. Nakai, H. Niwa, J. Miyazaki, T. Hamaoka, and M. Ogata. 2003. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8: 847-856.
28. Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A. Valladares, L. Perez, R. Klein, and A. R. Nebreda. 2000. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6: 109-116.
29. Allen, M., L. Svensson, M. Roach, J. Hambor, J. McNeish, and C. A. Gabel. 2000. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191: 859-870.
30. Tamura, K., T. Sudo, U. Senftleben, A. M. Dadak, R. Johnson, and M. Karin. 2000. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102: 221-231.
31. Brancho, D., N. Tanaka, A. Jaeschke, J. J. Ventura, N. Kelkar, Y. Tanaka, M. Kyuuma, T. Takeshita, R. A. Flavell, and R. J. Davis. 2003. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17: 1969-1978.
32. Kuan, C. Y., D. D. Yang, D. R. Samanta Roy, R. J. Davis, P. Rakic, and R. A. Flavell. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22: 667-676.
33. Nishina, H., C. Vaz, P. Billia, M. Nghiem, T. Sasaki, J. L. De la Pompa, K. Furlonger, C. Paige, C. Hui, K. D. Fischer, et al. 1999. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development 126: 505-516.
34. Muda, M., U. Boschert, A. Smith, B. Antonsson, C. Gillieron, C. Chabert, M. Camps, I. Martinou, A. Ashworth, and S. Arkinstall. 1997. Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4. J. Biol. Chem. 272: 5141-5151.
35. Christie, G. R., D. J. Williams, F. Macisaac, R. J. Dickinson, I. Rosewell, and S. M. Keyse. 2005. The dual-specificity protein phosphatase DUSP9/MKP-4 is essential for placental function but is not required for normal embryonic development. Mol. Cell. Biol. 25: 8323-8333.
36. Tanoue, T., T. Moriguchi, and E. Nishida. 1999. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J. Biol. Chem. 274: 19949-19956.
37. Tan, A. H., and K. P. Lam. 2010. Pharmacologic inhibition of MEK-ERK signaling enhances Th17 differentiation. J. Immunol. 184: 1849-1857.
38. Pulido, R., A. Zúñiga, and A. Ullrich. 1998. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17: 7337-7350.
39. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72.
40. Musikacharoen, T., K. Bandow, K. Kakimoto, J. Kusuyama, T. Onishi, Y. Yoshikai, and T. Matsuguchi. 2011. Functional involvement of dual specificity phosphatase 16 (DUSP16), a c-Jun N-terminal kinase-specific phosphatase, in the regulation of T helper cell differentiation. J. Biol. Chem. 286: 24896-24905.
41. Dong, C., D. D. Yang, C. Tournier, A. J. Whitmarsh, J. Xu, R. J. Davis, and R. A. Flavell. 2000. JNK is required for effector T-cell function but not for T-cell activation. Nature 405: 91-94.
42. Brereton, C. F., C. E. Sutton, S. J. Lalor, E. C. Lavelle, and K. H. Mills. 2009. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 183: 1715-1723.
43. -/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 176: 5788-5796.
44. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.
45. Constant, S. L., C. Dong, D. D. Yang, M. Wysk, R. J. Davis, and R. A. Flavell. 2000. JNK1 is required for T cell-mediated immunity against Leishmania major infection. J. Immunol. 165: 2671-2676.